Journal Article
. 2016 Jun; 15(12):2719-32.
doi: 10.1016/j.celrep.2016.05.058.

CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer

Katelyn T Byrne 1 Robert H Vonderheide 2 
  • PMID: 27292635
  •     72 References
  •     100 citations


Cancer immunotherapies are more effective in tumors with robust T cell infiltrates, but mechanisms to convert T cell-devoid tumors with active immunosuppression to those capable of recruiting T cells remain incompletely understood. Here, using genetically engineered mouse models of pancreatic ductal adenocarcinoma (PDA), we demonstrate that a single dose of agonistic CD40 antibody with chemotherapy rendered PDA susceptible to T cell-dependent destruction and potentiated durable remissions. CD40 stimulation caused a clonal expansion of T cells in the tumor, but the addition of chemotherapy optimized myeloid activation and T cell function. Although recent data highlight the requirement for innate sensors in cancer immunity, these canonical pathways-including TLRs, inflammasome, and type I interferon/STING-played no role in mediating the efficacy of CD40 and chemotherapy. Thus, CD40 functions as a non-redundant mechanism to convert the tumor microenvironment immunologically. Our data provide a rationale for a newly initiated clinical trial of CD40 and chemotherapy in PDA.

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Roy S Herbst, Jean-Charles Soria, +19 authors, F Stephen Hodi.
Nature, 2014 Nov 28; 515(7528). PMID: 25428504    Free PMC article.
Highly Cited.
Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.
Daniel Massó-Vallés, Toni Jauset, +9 authors, Laura Soucek.
Cancer Res, 2015 Apr 17; 75(8). PMID: 25878147    Free PMC article.
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.
R Alvarez, M Musteanu, +14 authors, M Hidalgo.
Br J Cancer, 2013 Aug 03; 109(4). PMID: 23907428    Free PMC article.
Highly Cited.
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
Dung T Le, Andrea Wang-Gillam, +19 authors, Elizabeth M Jaffee.
J Clin Oncol, 2015 Jan 15; 33(12). PMID: 25584002    Free PMC article.
Highly Cited.
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Bridget P Keenan, Yvonne Saenger, +11 authors, Elizabeth M Jaffee.
Gastroenterology, 2014 Mar 13; 146(7). PMID: 24607504    Free PMC article.
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.
E M Sotomayor, I Borrello, +6 authors, H I Levitsky.
Nat Med, 1999 Jul 08; 5(7). PMID: 10395323
Highly Cited.
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.
Rafael Winograd, Katelyn T Byrne, +8 authors, Robert H Vonderheide.
Cancer Immunol Res, 2015 Feb 14; 3(4). PMID: 25678581    Free PMC article.
Highly Cited.
nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Kristopher K Frese, Albrecht Neesse, +4 authors, David A Tuveson.
Cancer Discov, 2012 May 16; 2(3). PMID: 22585996    Free PMC article.
Highly Cited.
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.
François Ghiringhelli, Lionel Apetoh, +23 authors, Laurence Zitvogel.
Nat Med, 2009 Sep 22; 15(10). PMID: 19767732
Highly Cited.
Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
Carolyn E Clark, Sunil R Hingorani, +3 authors, Robert H Vonderheide.
Cancer Res, 2007 Oct 03; 67(19). PMID: 17909062
Highly Cited.
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Peter M K Westcott, Kyle D Halliwill, +11 authors, Allan Balmain.
Nature, 2014 Nov 05; 517(7535). PMID: 25363767    Free PMC article.
Highly Cited.
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.
Albrecht Neesse, Kristopher K Frese, +6 authors, David A Tuveson.
Gut, 2013 Sep 27; 63(6). PMID: 24067278    Free PMC article.
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
Robert H Vonderheide, Keith T Flaherty, +12 authors, Scott J Antonia.
J Clin Oncol, 2007 Mar 01; 25(7). PMID: 17327609
Highly Cited.
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.
R R French, H T Chan, A L Tutt, M J Glennie.
Nat Med, 1999 May 06; 5(5). PMID: 10229232
Highly Cited.
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Lionel Apetoh, François Ghiringhelli, +25 authors, Laurence Zitvogel.
Nat Med, 2007 Aug 21; 13(9). PMID: 17704786
Highly Cited.
TLR agonists: our best frenemy in cancer immunotherapy.
Sabina Kaczanowska, Ann Mary Joseph, Eduardo Davila.
J Leukoc Biol, 2013 Mar 12; 93(6). PMID: 23475577    Free PMC article.
Highly Cited. Review.
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.
Alain H Rook, Joel M Gelfand, +11 authors, Rachael A Clark.
Blood, 2015 Aug 01; 126(12). PMID: 26228486    Free PMC article.
Immunological aspects of cancer chemotherapy.
Laurence Zitvogel, Lionel Apetoh, François Ghiringhelli, Guido Kroemer.
Nat Rev Immunol, 2007 Dec 22; 8(1). PMID: 18097448
Highly Cited. Review.
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.
Yu Zhu, Brett L Knolhoff, +7 authors, David G DeNardo.
Cancer Res, 2014 Aug 02; 74(18). PMID: 25082815    Free PMC article.
Highly Cited.
IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma.
Kristen B Long, Whitney L Gladney, +3 authors, Gregory L Beatty.
Cancer Discov, 2016 Feb 21; 6(4). PMID: 26896096    Free PMC article.
Highly Cited.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, +20 authors, Markus F Renschler.
N Engl J Med, 2013 Oct 18; 369(18). PMID: 24131140    Free PMC article.
Highly Cited.
Consistency of Random Survival Forests.
Hemant Ishwaran, Udaya B Kogalur.
Stat Probab Lett, 2010 Jun 29; 80(13-14). PMID: 20582150    Free PMC article.
Ultra-sensitive detection of rare T cell clones.
Harlan Robins, Cindy Desmarais, +7 authors, Karen Cerosaletti.
J Immunol Methods, 2011 Sep 29; 375(1-2). PMID: 21945395    Free PMC article.
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma.
David L Bajor, Xiaowei Xu, +8 authors, Robert H Vonderheide.
Cancer Immunol Res, 2014 Sep 26; 2(11). PMID: 25252722    Free PMC article.
Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
S R Bennett, F R Carbone, +3 authors, W R Heath.
Nature, 1998 Jun 12; 393(6684). PMID: 9624004
Highly Cited.
The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
Leisha A Emens, Gary Middleton.
Cancer Immunol Res, 2015 May 06; 3(5). PMID: 25941355    Free PMC article.
Highly Cited. Review.
The future of immune checkpoint therapy.
Padmanee Sharma, James P Allison.
Science, 2015 Apr 04; 348(6230). PMID: 25838373
Highly Cited. Review.
Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
Leticia Corrales, Thomas F Gajewski.
Clin Cancer Res, 2015 Sep 17; 21(21). PMID: 26373573    Free PMC article.
Fine-tuning of dendritic cell biology by the TNF superfamily.
Leslie Summers deLuca, Jennifer L Gommerman.
Nat Rev Immunol, 2012 Apr 11; 12(5). PMID: 22487654
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.
Geertje J D van Mierlo, Annemieke Th den Boer, +5 authors, Rene E M Toes.
Proc Natl Acad Sci U S A, 2002 Apr 04; 99(8). PMID: 11929985    Free PMC article.
c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response.
Joshua J Woodward, Anthony T Iavarone, Daniel A Portnoy.
Science, 2010 May 29; 328(5986). PMID: 20508090    Free PMC article.
Highly Cited.
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
David G DeNardo, Donal J Brennan, +12 authors, Lisa M Coussens.
Cancer Discov, 2011 Nov 01; 1(1). PMID: 22039576    Free PMC article.
Highly Cited.
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.
Mark Cobbold, Hugo De La Peña, +19 authors, Victor H Engelhard.
Sci Transl Med, 2013 Sep 21; 5(203). PMID: 24048523    Free PMC article.
Highly Cited.
Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.
Sean O Ryan, Michael S Turner, Jean Gariépy, Olivera J Finn.
Cancer Res, 2010 Jul 01; 70(14). PMID: 20587526    Free PMC article.
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
Cory L Ahonen, Christie L Doxsee, +6 authors, Ross M Kedl.
J Exp Med, 2004 Mar 10; 199(6). PMID: 15007094    Free PMC article.
Highly Cited.
Inflammatory caspases are innate immune receptors for intracellular LPS.
Jianjin Shi, Yue Zhao, +5 authors, Feng Shao.
Nature, 2014 Aug 15; 514(7521). PMID: 25119034
Highly Cited.
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
Ingunn M Stromnes, Thomas M Schmitt, +8 authors, Sunil R Hingorani.
Cancer Cell, 2015 Nov 04; 28(5). PMID: 26525103    Free PMC article.
Highly Cited.
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Gregory L Beatty, Elena G Chiorean, +10 authors, Robert H Vonderheide.
Science, 2011 Mar 26; 331(6024). PMID: 21436454    Free PMC article.
Highly Cited.
Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination.
Ignacio Melero, Antonio M Grimaldi, Jose L Perez-Gracia, Paolo A Ascierto.
Clin Cancer Res, 2013 Mar 06; 19(5). PMID: 23460531
Highly Cited.
Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation.
Eric R Lutz, Annie A Wu, +14 authors, Lei Zheng.
Cancer Immunol Res, 2014 Jun 20; 2(7). PMID: 24942756    Free PMC article.
Highly Cited.
CANCER. The odds of immunotherapy success.
Matthew M Gubin, Robert D Schreiber.
Science, 2015 Oct 10; 350(6257). PMID: 26450194
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.
Metamia Ciampricotti, Cheei-Sing Hau, +2 authors, Karin E de Visser.
Nat Med, 2012 Mar 08; 18(3). PMID: 22395693
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.
Antonella Sistigu, Takahiro Yamazaki, +48 authors, Laurence Zitvogel.
Nat Med, 2014 Oct 27; 20(11). PMID: 25344738
Highly Cited.
Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase.
A Ding, E Sanchez, C F Nathan.
J Immunol, 1993 Nov 15; 151(10). PMID: 7901279
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Siân Jones, Xiaosong Zhang, +33 authors, Kenneth W Kinzler.
Science, 2008 Sep 06; 321(5897). PMID: 18772397    Free PMC article.
Highly Cited.
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
J P Ridge, F Di Rosa, P Matzinger.
Nature, 1998 Jun 12; 393(6684). PMID: 9624003
Highly Cited.
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
Cosimo Commisso, Shawn M Davidson, +11 authors, Dafna Bar-Sagi.
Nature, 2013 May 15; 497(7451). PMID: 23665962    Free PMC article.
Highly Cited.
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Christine Feig, James O Jones, +12 authors, Douglas T Fearon.
Proc Natl Acad Sci U S A, 2013 Nov 28; 110(50). PMID: 24277834    Free PMC article.
Highly Cited.
Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, +72 authors, Michael R Stratton.
Nature, 2013 Aug 16; 500(7463). PMID: 23945592    Free PMC article.
Highly Cited.
Immunogenic and tolerogenic cell death.
Douglas R Green, Thomas Ferguson, Laurence Zitvogel, Guido Kroemer.
Nat Rev Immunol, 2009 Apr 15; 9(5). PMID: 19365408    Free PMC article.
Highly Cited. Review.
The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides.
John-Demian Sauer, Katia Sotelo-Troha, +8 authors, Russell E Vance.
Infect Immun, 2010 Nov 26; 79(2). PMID: 21098106    Free PMC article.
Highly Cited.
STING/MPYS mediates host defense against Listeria monocytogenes infection by regulating Ly6C(hi) monocyte migration.
Lei Jin, Andrew Getahun, +5 authors, John C Cambier.
J Immunol, 2013 Feb 05; 190(6). PMID: 23378430    Free PMC article.
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.
Gregory L Beatty, Drew A Torigian, +8 authors, Peter J O'Dwyer.
Clin Cancer Res, 2013 Aug 29; 19(22). PMID: 23983255    Free PMC article.
Highly Cited.
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
S P Schoenberger, R E Toes, +2 authors, C J Melief.
Nature, 1998 Jun 12; 393(6684). PMID: 9624005
Highly Cited.
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
Christina Twyman-Saint Victor, Andrew J Rech, +22 authors, Andy J Minn.
Nature, 2015 Mar 11; 520(7547). PMID: 25754329    Free PMC article.
Highly Cited.
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Seng-Ryong Woo, Mercedes B Fuertes, +9 authors, Thomas F Gajewski.
Immunity, 2014 Dec 18; 41(5). PMID: 25517615    Free PMC article.
Highly Cited.
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
Sunil R Hingorani, Lifu Wang, +6 authors, David A Tuveson.
Cancer Cell, 2005 May 17; 7(5). PMID: 15894267
Highly Cited.
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
Daniel D Von Hoff, Ramesh K Ramanathan, +13 authors, Manuel Hidalgo.
J Clin Oncol, 2011 Oct 05; 29(34). PMID: 21969517    Free PMC article.
Highly Cited.
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.
Kevin C Soares, Agnieszka A Rucki, +15 authors, Lei Zheng.
J Immunother, 2014 Nov 22; 38(1). PMID: 25415283    Free PMC article.
Highly Cited.
Tertiary lymphoid structures in cancer and beyond.
Marie-Caroline Dieu-Nosjean, Jérémy Goc, +2 authors, Wolf Herman Fridman.
Trends Immunol, 2014 Dec 03; 35(11). PMID: 25443495
Highly Cited. Review.
Immunogenicity of somatic mutations in human gastrointestinal cancers.
Eric Tran, Mojgan Ahmadzadeh, +10 authors, Steven A Rosenberg.
Science, 2015 Nov 01; 350(6266). PMID: 26516200    Free PMC article.
Highly Cited.
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
Cory L Ahonen, Anna Wasiuk, +7 authors, Randolph J Noelle.
Blood, 2008 Jan 19; 111(6). PMID: 18202224    Free PMC article.
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Anna K Nowak, Bruce W S Robinson, Richard A Lake.
Cancer Res, 2003 Aug 09; 63(15). PMID: 12907622
Highly Cited.
Agonistic CD40 antibodies and cancer therapy.
Robert H Vonderheide, Martin J Glennie.
Clin Cancer Res, 2013 Mar 06; 19(5). PMID: 23460534    Free PMC article.
Highly Cited.
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.
Albert Lo, Liang-Chuan S Wang, +13 authors, Ellen Puré.
Cancer Res, 2015 May 17; 75(14). PMID: 25979873    Free PMC article.
Highly Cited.
tcR: an R package for T cell receptor repertoire advanced data analysis.
Vadim I Nazarov, Mikhail V Pogorelyy, +6 authors, Ilgar Z Mamedov.
BMC Bioinformatics, 2015 May 29; 16. PMID: 26017500    Free PMC article.
Highly Cited.
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Liufu Deng, Hua Liang, +12 authors, Ralph R Weichselbaum.
Immunity, 2014 Dec 18; 41(5). PMID: 25517616    Free PMC article.
Highly Cited.
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.
Gregory L Beatty, Rafael Winograd, +8 authors, Robert H Vonderheide.
Gastroenterology, 2015 Apr 19; 149(1). PMID: 25888329    Free PMC article.
Highly Cited.
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, +23 authors, Jon M Wigginton.
N Engl J Med, 2012 Jun 05; 366(26). PMID: 22658128    Free PMC article.
Highly Cited.
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
L Diehl, A T den Boer, +5 authors, R E Toes.
Nat Med, 1999 Jul 08; 5(7). PMID: 10395322
Highly Cited.
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, +7 authors, Gad Getz.
Nat Biotechnol, 2013 Feb 12; 31(3). PMID: 23396013    Free PMC article.
Highly Cited.
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.
Mark Sausen, Jillian Phallen, +23 authors, Victor E Velculescu.
Nat Commun, 2015 Jul 15; 6. PMID: 26154128    Free PMC article.
Highly Cited.
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.
Rebecca A Evans, Mark S Diamond, +10 authors, Robert H Vonderheide.
JCI Insight, 2016 Sep 20; 1(14). PMID: 27642636    Free PMC article.
Highly Cited.
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Kazuyuki Sogawa, Shigetsugu Takano, +13 authors, Fumio Nomura.
Br J Cancer, 2016 Sep 23; 115(8). PMID: 27657339    Free PMC article.
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.
Timothy Chao, Emma E Furth, Robert H Vonderheide.
Cancer Immunol Res, 2016 Nov 03; 4(11). PMID: 27737879    Free PMC article.
Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.
Gregory L Beatty, Yan Li, Kristen B Long.
Expert Rev Anticancer Ther, 2016 Dec 09; 17(2). PMID: 27927088    Free PMC article.
Macrophage regulation of B cell proliferation.
Naomi Goldman, Kornelija Valiuskyte, +3 authors, James E Riggs.
Cell Immunol, 2017 Feb 28; 314. PMID: 28238361    Free PMC article.
Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.
Jung-Eun Jang, Cristina H Hajdu, +3 authors, Dafna Bar-Sagi.
Cell Rep, 2017 Jul 21; 20(3). PMID: 28723561    Free PMC article.
Highly Cited.
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Manisha Singh, Christina Vianden, +15 authors, Willem W Overwijk.
Nat Commun, 2017 Nov 14; 8(1). PMID: 29129918    Free PMC article.
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.
Mariona Cabo, Rienk Offringa, +3 authors, Lorenzo Galluzzi.
Oncoimmunology, 2017 Dec 07; 6(12). PMID: 29209572    Free PMC article.
Emerging trends in the immunotherapy of pancreatic cancer.
Kasturi Banerjee, Sushil Kumar, +10 authors, Maneesh Jain.
Cancer Lett, 2017 Dec 16; 417. PMID: 29242097    Free PMC article.
Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors.
Lindsay K Ward-Kavanagh, Kathleen M Kokolus, +2 authors, Todd D Schell.
Cancer Immunol Immunother, 2018 Jan 15; 67(4). PMID: 29332158    Free PMC article.
The Immune Revolution: A Case for Priming, Not Checkpoint.
Robert H Vonderheide.
Cancer Cell, 2018 Apr 11; 33(4). PMID: 29634944    Free PMC article.
Highly Cited. Review.
A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology.
Robert E Van Sciver, Michael P Lee, +13 authors, Amy H Tang.
Cancers (Basel), 2018 May 15; 10(5). PMID: 29757973    Free PMC article.
Immunotherapy and Prevention of Pancreatic Cancer.
Alexander H Morrison, Katelyn T Byrne, Robert H Vonderheide.
Trends Cancer, 2018 Jun 05; 4(6). PMID: 29860986    Free PMC article.
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma.
Daniel H Ahn, Ramesh K Ramanathan, Tanios Bekaii-Saab.
Cancers (Basel), 2018 Jun 13; 10(6). PMID: 29891787    Free PMC article.
Immunotherapy for pancreatic cancer: Barriers and breakthroughs.
Robert J Torphy, Yuwen Zhu, Richard D Schulick.
Ann Gastroenterol Surg, 2018 Jul 14; 2(4). PMID: 30003190    Free PMC article.
Highly Cited. Review.
Emerging strategies for combination checkpoint modulators in cancer immunotherapy.
Aleksandra Popovic, Elizabeth M Jaffee, Neeha Zaidi.
J Clin Invest, 2018 Aug 02; 128(8). PMID: 30067248    Free PMC article.
Highly Cited. Review.
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
Derya Kabacaoglu, Katrin J Ciecielski, Dietrich A Ruess, Hana Algül.
Front Immunol, 2018 Aug 31; 9. PMID: 30158932    Free PMC article.
Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer.
Sayeda Yasmin-Karim, Patrick T Bruck, +6 authors, Wilfred Ngwa.
Front Immunol, 2018 Sep 25; 9. PMID: 30245691    Free PMC article.
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.
Olga S Blomberg, Lorenzo Spagnuolo, Karin E de Visser.
Dis Model Mech, 2018 Oct 26; 11(10). PMID: 30355585    Free PMC article.
Age-Related Changes on CD40 Promotor Methylation and Immune Gene Expressions in Thymus of Chicken.
Yulong Li, Xinyu Lei, +5 authors, Xiaojun Yang.
Front Immunol, 2018 Dec 07; 9. PMID: 30519246    Free PMC article.
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers.
Karoline Kielbassa, Serena Vegna, Christel Ramirez, Leila Akkari.
Front Immunol, 2019 Oct 16; 10. PMID: 31611871    Free PMC article.
Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Xiaolei Li, Rui Liu, +4 authors, Yufang Shi.
Mol Cancer, 2019 Dec 07; 18(1). PMID: 31805946    Free PMC article.
Enterotoxins can support CAR T cells against solid tumors.
Bianca von Scheidt, Minyu Wang, +9 authors, Clare Y Slaney.
Proc Natl Acad Sci U S A, 2019 Nov 27; 116(50). PMID: 31767744    Free PMC article.
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.
Shetal A Patel, Andy J Minn.
Immunity, 2018 Mar 22; 48(3). PMID: 29562193    Free PMC article.
Highly Cited. Review.
Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma.
Veethika Pandey, Peter Storz.
Expert Rev Anticancer Ther, 2019 Jun 01; 19(6). PMID: 31148495    Free PMC article.
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.
Eva Karamitopoulou.
Br J Cancer, 2019 May 22; 121(1). PMID: 31110329    Free PMC article.
Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer.
Andrew J Rech, Hannah Dada, +4 authors, Robert H Vonderheide.
Cancer Res, 2018 May 31; 78(15). PMID: 29844122    Free PMC article.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Christopher S Garris, Sean P Arlauckas, +20 authors, Mikael J Pittet.
Immunity, 2018 Dec 16; 49(6). PMID: 30552023    Free PMC article.
Highly Cited.
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.
Vinod P Balachandran, Gregory L Beatty, Stephanie K Dougan.
Gastroenterology, 2019 Jan 21; 156(7). PMID: 30660727    Free PMC article.
Highly Cited. Review.
Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
Ligia I Bastea, Geou-Yarh Liou, +9 authors, Peter Storz.
Cancer Res, 2019 Jan 31; 79(7). PMID: 30696657    Free PMC article.
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
Nicholas F Kuhn, Terence J Purdon, +4 authors, Renier J Brentjens.
Cancer Cell, 2019 Mar 20; 35(3). PMID: 30889381    Free PMC article.
Highly Cited.
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer.
Meredith L Stone, Gregory L Beatty.
Pharmacol Ther, 2019 Jun 04; 201. PMID: 31158393    Free PMC article.
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.
Danny N Khalil, Nathan Suek, +18 authors, Taha Merghoub.
J Clin Invest, 2019 Jul 23; 129(8). PMID: 31329159    Free PMC article.
Concepts for agonistic targeting of CD40 in immuno-oncology.
David M Richards, Julian P Sefrin, +2 authors, Christian Merz.
Hum Vaccin Immunother, 2019 Aug 14; 16(2). PMID: 31403344    Free PMC article.
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.
Ingunn M Stromnes, Adam L Burrack, +8 authors, Sunil R Hingorani.
Cancer Immunol Res, 2019 Apr 28; 7(6). PMID: 31028033    Free PMC article.
Recent insights into the biology of pancreatic cancer.
Wantong Yao, Anirban Maitra, Haoqiang Ying.
EBioMedicine, 2020 Mar 07; 53. PMID: 32139179    Free PMC article.
Modulating inflammation for cancer therapy.
Birgit Ritter, Florian R Greten.
J Exp Med, 2019 Apr 27; 216(6). PMID: 31023715    Free PMC article.
Highly Cited. Review.
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
Rajkumar Noubade, Sonia Majri-Morrison, Kristin V Tarbell.
Front Immunol, 2019 May 31; 10. PMID: 31143179    Free PMC article.
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity.
Alexander H Morrison, Mark S Diamond, +2 authors, Robert H Vonderheide.
Proc Natl Acad Sci U S A, 2020 Mar 28; 117(14). PMID: 32213589    Free PMC article.
Tumor Cell-Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer.
Jinyang Li, Salina Yuan, +4 authors, Ben Z Stanger.
Cancer Immunol Res, 2019 Dec 25; 8(3). PMID: 31871120    Free PMC article.
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
Samarth Hegde, Varintra E Krisnawan, +16 authors, David G DeNardo.
Cancer Cell, 2020 Mar 19; 37(3). PMID: 32183949    Free PMC article.
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy.
Daniel Baumann, Tanja Hägele, +12 authors, Rienk Offringa.
Nat Commun, 2020 May 03; 11(1). PMID: 32358491    Free PMC article.
CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity.
Austin P Huffman, Jeffrey H Lin, +2 authors, Robert H Vonderheide.
JCI Insight, 2020 Apr 24; 5(10). PMID: 32324594    Free PMC article.
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).
Nune Markosyan, Jinyang Li, +13 authors, Robert H Vonderheide.
J Clin Invest, 2019 Jun 05; 129(9). PMID: 31162144    Free PMC article.
Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.
Simone Ragusa, Borja Prat-Luri, +17 authors, Tatiana V Petrova.
J Clin Invest, 2020 Feb 06; 130(3). PMID: 32015230    Free PMC article.
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
Saber Amin, Michael Baine, +2 authors, Chi Lin.
Radiat Oncol, 2020 Jun 05; 15(1). PMID: 32493354    Free PMC article.
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
Saber Amin, Michael Baine, Jane Meza, Chi Lin.
BMC Cancer, 2020 Jun 11; 20(1). PMID: 32517661    Free PMC article.
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor.
Saber Amin, Michael Baine, +2 authors, Chi Lin.
Clin Transl Radiat Oncol, 2020 Jul 03; 24. PMID: 32613090    Free PMC article.
Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell.
Nat Rev Immunol, 2019 Feb 06; 19(6). PMID: 30718830    Free PMC article.
Highly Cited. Review.
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
Chunxiao Li, Ping Jiang, +2 authors, Junjie Wang.
Mol Cancer, 2020 Jul 19; 19(1). PMID: 32680511    Free PMC article.
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.
Renee B Chang, Gregory L Beatty.
J Leukoc Biol, 2020 Apr 10; 108(1). PMID: 32272502    Free PMC article.
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
Jinyang Li, Katelyn T Byrne, +26 authors, Ben Z Stanger.
Immunity, 2018 Jul 01; 49(1). PMID: 29958801    Free PMC article.
Highly Cited.
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis.
Jeffrey H Lin, Austin P Huffman, +6 authors, Robert H Vonderheide.
J Exp Med, 2020 May 27; 217(8). PMID: 32453421    Free PMC article.
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Jonas Rm Van Audenaerde, Elly Marcq, +13 authors, Evelien Ljm Smits.
Clin Transl Immunology, 2020 Aug 22; 9(8). PMID: 32821382    Free PMC article.
T-Cell Immunity in Pancreatic Cancer.
Reham Ajina, Louis M Weiner.
Pancreas, 2020 Aug 25; 49(8). PMID: 32833941    Free PMC article.
Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle.
Snehal Gajiwala, Anna Torgeson, +2 authors, Shane Lloyd.
J Gastrointest Oncol, 2019 Jan 04; 9(6). PMID: 30603120    Free PMC article.
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer.
Belinda Lee, Peter Gibbs.
J Pers Med, 2019 May 01; 9(2). PMID: 31035449    Free PMC article.
The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database.
Saber Amin, Michael J Baine, Jane L Meza, Chi Lin.
Front Oncol, 2020 Sep 29; 10. PMID: 32983998    Free PMC article.
The Achilles' Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials.
Despina Siolas, Christy Morrissey, Paul Eliezer Oberstein.
J Pancreatol, 2020 Nov 03; 3(3). PMID: 33133736    Free PMC article.
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy.
David J Zahavi, Louis M Weiner.
Int J Mol Sci, 2019 Jan 10; 20(1). PMID: 30621125    Free PMC article.
Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer.
Robert H Vonderheide, Adham S Bear.
Front Immunol, 2020 Dec 12; 11. PMID: 33304355    Free PMC article.
Challenges and Opportunities for Pancreatic Cancer Immunotherapy.
Adham S Bear, Robert H Vonderheide, Mark H O'Hara.
Cancer Cell, 2020 Sep 19; 38(6). PMID: 32946773    Free PMC article.
Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.
Brett Z Fite, James Wang, +16 authors, Katherine W Ferrara.
Sci Rep, 2021 Jan 15; 11(1). PMID: 33441763    Free PMC article.
The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment.
Maximilian Haist, Henner Stege, Stephan Grabbe, Matthias Bros.
Cancers (Basel), 2021 Jan 13; 13(2). PMID: 33430105    Free PMC article.
CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Moran Yang, Jiaqi Lu, +5 authors, Haiou Liu.
J Immunother Cancer, 2021 Jan 17; 9(1). PMID: 33452206    Free PMC article.
Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes.
Samuel I Kim, Christopher R Cassella, Katelyn T Byrne.
Front Immunol, 2021 Feb 19; 11. PMID: 33597954    Free PMC article.
Targeting Innate Immunity in Cancer Therapy.
Srikrishnan Rameshbabu, Brian W Labadie, Anna Argulian, Akash Patnaik.
Vaccines (Basel), 2021 Feb 13; 9(2). PMID: 33572196    Free PMC article.
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.
Jinyang Li, Salina Yuan, +11 authors, Ben Z Stanger.
Cancer Discov, 2020 Nov 08; 11(3). PMID: 33158848    Free PMC article.
The role of tumor heterogeneity in immune-tumor interactions.
Shelby M Knoche, Alaina C Larson, +2 authors, Joyce C Solheim.
Cancer Metastasis Rev, 2021 Mar 09; 40(2). PMID: 33682030    Free PMC article.
Agonistic CD40 Antibodies in Cancer Treatment.
Dijana Djureinovic, Meina Wang, Harriet M Kluger.
Cancers (Basel), 2021 Apr 04; 13(6). PMID: 33804039    Free PMC article.
Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patients.
Max M Wattenberg, Veronica M Herrera, +3 authors, Gregory L Beatty.
JCI Insight, 2021 Jan 27; 6(5). PMID: 33497362    Free PMC article.
Therapeutic potential of interleukin-15 in cancer (Review).
Gheorghita Isvoranu, Mihaela Surcel, +4 authors, Marioara Chiritoiu-Butnaru.
Exp Ther Med, 2021 May 15; 22(1). PMID: 33986840    Free PMC article.
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity.
Xiang Ling, Xiaomin Jiang, +4 authors, Wenbin Lin.
ACS Nano, 2020 Dec 22; 15(1). PMID: 33347262    Free PMC article.
C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
Kosuke Sasaki, Shigetsugu Takano, +6 authors, Masayuki Ohtsuka.
J Exp Clin Cancer Res, 2021 Jun 26; 40(1). PMID: 34167573    Free PMC article.
Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.
Ce Li, Zhenzi Peng, +8 authors, Qiang Wang.
Am J Physiol Gastrointest Liver Physiol, 2021 Jan 28; 320(3). PMID: 33501895    Free PMC article.
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges.
Ashleigh R Poh, Matthias Ernst.
Cancers (Basel), 2021 Jul 03; 13(12). PMID: 34201127    Free PMC article.
Ovarian Cancer Immunotherapy and Personalized Medicine.
Susan Morand, Monika Devanaboyina, +2 authors, John Nemunaitis.
Int J Mol Sci, 2021 Jul 03; 22(12). PMID: 34207103    Free PMC article.
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.
Luuk van Hooren, Alessandra Vaccaro, +16 authors, Anna Dimberg.
Nat Commun, 2021 Jul 07; 12(1). PMID: 34226552    Free PMC article.
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer.
Raphaël Mattiuz, Carine Brousse, +9 authors, Karine Crozat.
Clin Transl Immunology, 2021 Jul 20; 10(7). PMID: 34277006    Free PMC article.
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies.
Timothy N J Bullock.
Cell Mol Immunol, 2021 Jul 21; 19(1). PMID: 34282297    Free PMC article.
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.
Christopher S Garris, Jeffrey L Wong, Jeffrey V Ravetch, David A Knorr.
Sci Transl Med, 2021 May 21; 13(594). PMID: 34011627    Free PMC article.
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy.
Meredith L Stone, Jesse Lee, +11 authors, Gregory L Beatty.
JCI Insight, 2021 Jun 09; 6(14). PMID: 34101617    Free PMC article.
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.
Sadaf Aghevlian, Bo Wu, +4 authors, Katherine W Ferrara.
Nucl Med Biol, 2021 May 08; 98-99. PMID: 33962357    Free PMC article.
Tumour-intrinsic resistance to immune checkpoint blockade.
Anusha Kalbasi, Antoni Ribas.
Nat Rev Immunol, 2019 Oct 02; 20(1). PMID: 31570880    Free PMC article.
Highly Cited. Review.
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer.
William A Freed-Pastor, Laurens J Lambert, +21 authors, Tyler Jacks.
Cancer Cell, 2021 Aug 07; 39(10). PMID: 34358448    Free PMC article.
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer.
Peter M K Westcott, Nathan J Sacks, +13 authors, Tyler Jacks.
Nat Cancer, 2021 Nov 06; 2(10). PMID: 34738089    Free PMC article.
Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer.
Courtney T Stump, Kevin Roehle, Nataly Manjarrez Orduno, Stephanie K Dougan.
Open Biol, 2021 Nov 18; 11(11). PMID: 34784792    Free PMC article.
Immunotherapy in Pancreatic Adenocarcinoma: Beyond "Copy/Paste".
Robert Hester, Pawel K Mazur, Florencia McAllister.
Clin Cancer Res, 2021 Jul 02; 27(23). PMID: 34193514    Free PMC article.
Brief exposure of skin to near-infrared laser augments early vaccine responses.
Shinya Yokomizo, Wataru Katagiri, +8 authors, Satoshi Kashiwagi.
Nanophotonics, 2021 Dec 07; 10(12). PMID: 34868804    Free PMC article.
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Katelyn T Byrne, Courtney B Betts, +26 authors, Robert H Vonderheide.
Clin Cancer Res, 2021 Jun 12; 27(16). PMID: 34112709    Free PMC article.
Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming.
Mark S Diamond, Jeffrey H Lin, Robert H Vonderheide.
Cancer Immunol Res, 2021 Jun 20; 9(8). PMID: 34145076    Free PMC article.
Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy.
Despina Siolas, Emily Vucic, +2 authors, Dafna Bar-Sagi.
Cell Rep, 2021 Aug 26; 36(8). PMID: 34433022    Free PMC article.
Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment.
Takashi Watanabe.
Cancers (Basel), 2022 Jan 12; 14(1). PMID: 35008305    Free PMC article.
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility.
Yuanshuai Su, Xinyu Gu, +3 authors, Lanjuan Li.
Front Oncol, 2022 Mar 11; 12. PMID: 35265529    Free PMC article.
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights.
Christo Kole, Nikolaos Charalampakis, +3 authors, Dimitrios Schizas.
Cancer Manag Res, 2022 Mar 19; 14. PMID: 35300059    Free PMC article.
Translational advances in pancreatic ductal adenocarcinoma therapy.
Abdel Nasser Hosein, Stephanie K Dougan, Andrew J Aguirre, Anirban Maitra.
Nat Cancer, 2022 Mar 31; 3(3). PMID: 35352061
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer.
Adam L Burrack, Zoe C Schmiechen, +8 authors, Ingunn M Stromnes.
JCI Insight, 2022 Apr 09; 7(7). PMID: 35393950    Free PMC article.
A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy.
Yu Fujiwara, Arjun Mittra, Abdul Rafeh Naqash, Naoko Takebe.
Cancer Drug Resist, 2020 Jun 18; 3(3). PMID: 35582437    Free PMC article.
The dark side of immunotherapy: pancreatic cancer.
Gianluca Mucciolo, Cecilia Roux, +3 authors, Paola Cappello.
Cancer Drug Resist, 2020 May 11; 3(3). PMID: 35582441    Free PMC article.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Lacey J Padrón, Deena M Maurer, +34 authors, Robert H Vonderheide.
Nat Med, 2022 Jun 07;. PMID: 35662283